| Victoza (liraglutide) / Novo Nordisk |
2013-002348-99: The effect of liraglutide on arterial blood pressure in hypertensive patients with type 2 diabetes mellitus Mελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2 |
|
|
| Ongoing | 3 | 112 | Europe | VIctoza, Solution for injection in pre-filled pen, Victoza | Aristotle University Thessaloniki, NOVO NORDISK HELLAS | Hypertention, Type 2 Diabetes Υπέρταση, Διαβήτης τύπου 2, Hypertention, Diabetes Υπέρταση, Διαβήτης, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
2011-001538-41: GLIDE: Gastric band and Liraglutide Intervention in Diabetes Evolution |
|
|
| Ongoing | 3 | 200 | Europe | Liraglutide, Victoza 6 mg/ml solution for injection in pre-filled pen, Victoza 6 mg/ml solution for injection in pre-filled pen | University of Birmingham | This trial will investigate the effects of the study treatment arms (gastric band + placebo; gastric band + liraglutide) on diabetes resolution in obese patients. | | | | |
2011-004955-38: Controlling Glucose during Elective hip Surgery to study the influence on Coagulation |
|
|
| Ongoing | 3 | 36 | Europe | Victoza, EMEA/H/C/001026, Victoza, Victoza | AMC, Amsterdam, AMC, Amsterdam, Novo Nordisk | patients who will undergo elective hip surgery with a hyperglycemic period perioperatively due to surgery. | | | | |
2010-024024-14: INVESTIGACION DE LA OBESIDAD EN LAS INCRETINAS:EVALUACIÓN DE NUEVOS TRATAMIENTOS DE DIABETES.EFECTO DE LOS TRATAMIENTOS CON INSULINA, LIRAGLUTIDE Y CIRUGÍA BARIÁTRICA EN LA MEJORIA DE LA DIABETES TIPO II EN PACIENTES CON OBESIDAD GRADO I |
|
|
| Ongoing | 3 | 150 | Europe | VICTOZA 6 mg/ml solución inyectable en pluma precargada, DIANBEN 850 mg comprimidos recubiertos con película, LEVEMIR 100 U/ml, solución inyectable en una pluma precargada, VICTOZA 6 mg/ml solución inyectable en pluma precargada, DIANBEN 850 mg comprimidos recubiertos con película, LEVEMIR 100 U/ml, solución inyectable en una pluma precargada | CAIBER | DIABETES MELLITUS TIPO II (DMTII) | | | | |
2014-003298-40: STUDY OF THE EFFICACY AND SAFETY OF LIRAGLUTIDE IN TYPE 2 DIABETIC PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROME. IMPACT ON CARDIOVASCULAR RISK FACTOR. ESTUDIO DE LA EFICACIA Y SEGURIDAD DE LIRAGLUTIDA EN EL PACIENTE DIABÉTICO TIPO 2 HOSPITALIZADO CON SÍNDROME CORONARIO AGUDO. IMPACTO SOBRE FACTOR DE RIESGO CARDIOVASCULAR. |
|
|
| Ongoing | 3 | 80 | Europe | liraglutide, glargine insulin, VICTOZA, LANTUS, VICTOZA, LANTUS | Instituto de Investigación La Fe, Instituto de Investigación Sanitaria La Fe | TYPE 2 DIABETIC HOSPITALIZED PATIENTS WITH ACUTE CORONARY SYNDROME. PACIENTE DIABÉTICO TIPO 2 HOSPITALIZADO CON SÍNDROME CORONARIO AGUDO. | | | | |
ACTRN12613001069741: The combined effect of Liraglutide and Sleeve Gastrectomy on Metabolic, Cardiac, Neurological and Sleep Function in Obese Diabetes: A Twelve-Month Randomised Study. |
|
|
| Active, not recruiting | 3 | 120 | | | Northern Sydney Local Health District, Novo Nordisk | Type 2 Diabetes Mellitus, Obesity | | | | |
2017-005032-42: Effect of Liraglutide on the Metabolic Profile in Patients with Type 2 Diabetes and Cardiovascular Disease Effekt von Liraglutid auf das Stoffwechselprofil in Patienten mit Typ 2 Diabetes und Herz-Kreislauf-Erkrankung |
|
|
| Not yet recruiting | 3 | 50 | Europe | Liraglutid, Injection, Victoza | RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty, Novo Nordisk | Diabetes Type 2 with existing cardiovascular disease Diabetes Typ 2 mit bestehender kardiovaskulärer Erkrankung, Diabetes Type 2 with existing cardiovascular disease Diabetes Typ 2 mit bestehender Herz-Kreislauf-Erkrankung, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes |
|
|
| Recruiting | 3 | 424 | RoW | Victoza®., Metformin Hydrochloride, TQZ2451 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Type 2 Diabetes | 12/21 | 12/21 | | |
NCT03986008: Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients |
|
|
| Recruiting | 3 | 60 | RoW | Benaglutide, rhGLP-1(7-36), Liraglutide, Victoza | Xiangya Hospital of Central South University | Obesity | 12/21 | 12/21 | | |
NCT04487743: Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities |
|
|
| Recruiting | 3 | 300 | RoW | Liraglutide, S20200402, placebo, S20200301 | Xiangya Hospital of Central South University | Obesity | 06/22 | 06/22 | | |
NCT04525300: Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities |
|
|
| Recruiting | 3 | 300 | RoW | Liraglutide, S20200402, placebo, S20200301 | Xiangya Hospital of Central South University | Obesity | 06/22 | 06/22 | | |
NCT03671733: Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients |
|
|
| Recruiting | 3 | 150 | RoW | Liraglutide, Victoza, Exenatide, Byetta, Exenatide Microspheres for Injection, Bydureon | Xiangya Hospital of Central South University | Obesity | 09/22 | 09/22 | | |
NCT04605861: The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients |
|
|
| Completed | 3 | 414 | RoW | Liraglutide, Placebo | Shanghai Zhongshan Hospital | Obese, Overweight | 12/22 | 04/23 | | |
| Recruiting | 3 | 478 | | Liraglutide injection ;Novol injection | West China Hospital of Sichuan University; West China Hospital of Sichuan University, Chongqing Chen 'an Bio-Pharmaceutical Co. Ltd | Type 2 diabetes | | | | |
NCT05467514: Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus |
|
|
| Completed | 3 | 35 | RoW | Liraglutide | David Sanchez Garcia, Instituto Mexicano del Seguro Social | Diabetes Mellitus, Type 1 | 02/23 | 02/23 | | |
| Active, not recruiting | 3 | 78 | Europe, US, RoW | Liraglutide, Placebo | Novo Nordisk A/S | Obesity | 08/23 | 01/27 | | |
NCT02516657: Liraglutide in Adolescents With Type 1 Diabetes |
|
|
| Active, not recruiting | 3 | 5 | US | Liraglutide, Victoza | University at Buffalo | Type 1 Diabetes | 12/23 | 12/24 | | |
NCT06361238: Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery |
|
|
| Not yet recruiting | 3 | 260 | NA | Liraglutide injection, Victoza, Placebo injection, Normal saline | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Delirium, Postoperative | 03/26 | 03/27 | | |
NCT05952882: Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility |
|
|
| Not yet recruiting | 3 | 188 | NA | Liraglutide + Metformin, LIME, Metformin, MET | Mỹ Đức Hospital | Polycystic Ovary Syndrome, Obesity, Infertility, Female | 12/25 | 12/25 | | |
